KRMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
KORU Medical Systems Inc (KRMD) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has a positive growth outlook, supported by a recent analyst upgrade, strong revenue growth, and a favorable technical setup. While there are some financial weaknesses, the long-term potential outweighs the risks.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 45.341, and moving averages are converging, suggesting a potential breakout. The stock is trading near its pivot point of 4.317, with resistance levels at 4.477 and 4.576, providing room for upside.
B. Riley raised the price target to $8 from $7 with a Buy rating, citing strong execution across strategic pillars.
Revenue growth of 23.27% YoY in Q4 2025 demonstrates strong operational performance.
Technical indicators suggest bullish momentum.
Net income dropped significantly by -68.81% YoY, and EPS declined by -66.67%, reflecting profitability challenges.
Gross margin slightly decreased by -0.64% YoY, indicating potential cost pressures.
In Q4 2025, revenue increased by 23.27% YoY to $10.89 million, showcasing strong growth. However, net income dropped by -68.81% YoY to -$486,856, and EPS fell by -66.67% to -0.01, signaling profitability challenges. Gross margin slightly decreased to 60.93%, down -0.64% YoY.
B. Riley recently raised the price target to $8 from $7 and reiterated a Buy rating, citing strong execution across strategic pillars. This reflects positive sentiment from analysts.
